Overview
Helena Rodbard is an Endocrinologist in Rockville, Maryland. Dr. Rodbard is rated as an Elite provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Type 2 Diabetes (T2D), Low Blood Sugar, Maturity Onset Diabetes of the Young, and Type 1 Diabetes (T1D).
Her clinical research consists of co-authoring 73 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 17 articles in the study of Low Blood Sugar.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3200 Tower Oaks Blvd Ste 250, Rockville, MD 20852
Additional Areas of Focus
Dr. Rodbard has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
University Of Maryland Pediatric Associates PA
Rozalina Mccoy is an Endocrinologist in Baltimore, Maryland. Dr. Mccoy has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Low Blood Sugar. Her top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Diabetic Hyperglycemic Hyperosmolar Syndrome.
Wrnmmcb
Robert Vigersky is an Endocrinologist in Bethesda, Maryland. Dr. Vigersky is rated as a Distinguished provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Low Blood Sugar, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.
Johns Hopkins Outpatient Center
Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics. Dr. Mathioudakis is rated as an Advanced provider by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Low Blood Sugar, Maturity Onset Diabetes of the Young, and Pancreaticoduodenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Low Blood SugarDr. Rodbard isElite. Learn about Low Blood Sugar.
- Type 2 Diabetes (T2D)Dr. Rodbard isElite. Learn about Type 2 Diabetes (T2D).
- Distinguished
- Maturity Onset Diabetes of the YoungDr. Rodbard isDistinguished. Learn about Maturity Onset Diabetes of the Young.
- Advanced
- Type 1 Diabetes (T1D)Dr. Rodbard isAdvanced. Learn about Type 1 Diabetes (T1D).
- Experienced
- Diabetic KetoacidosisDr. Rodbard isExperienced. Learn about Diabetic Ketoacidosis.
- Heart Failure with Preserved Ejection Fraction (HFpEF)
- HypothyroidismDr. Rodbard isExperienced. Learn about Hypothyroidism.
- ObesityDr. Rodbard isExperienced. Learn about Obesity.